Delivery Order SPE2DB20D3103-SPE2DB21FQ1A5
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Keytruda 100 mg/4 ml vials. The $202,369.20 fixed-price delivery order has a period of performance through February 28, 2023 and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $76,403.88 firm fixed-price delivery order is for the pharmaceutical product KEYTRUDA 100 MG/4 ML VIAL 4ML, with a completion date of September 10, 2021. The contract is not designated as a set-aside award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, particularly...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $78,114.24 contract is for the supply of KEYTRUDA 100 MG/4 ML VIAL 4ML, a specialty oncology medication. This order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
- This federal contract award, valued at $78,114.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order for the supply of KEYTRUDA 100 MG/4 ML VIAL 4ML, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is to supply Keytruda 100 mg/4 ml vials, with a potential value of $101,184.60 and a completion date of February 27, 2023. Amerisourcebergen Drug Corp has previously received numerous federal contract awards from DLA to provide pharmaceutical products and medical supplies in support of military...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $78,114.24 Firm Fixed Price Delivery Order is for the supply of KEYTRUDA 100 MG/4 ML VIAL 4ML, a specialty pharmaceutical product. The contract has an ultimate completion date of June 7, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides for the delivery of KEYTRUDA 100 MG/4 ML VIAL 4ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $94,188.00 Firm Fixed Price delivery order was awarded on November 10, 2021, with a completion date of December 3, 2021. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $76,403.88, is for the delivery of Keytruda 100 mg/4 ml vials, a specialty cancer medication. The contract is a delivery order with a firm fixed price and has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which operates...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $32,114.28, is for the delivery of Keytruda 100 mg/4 ml vial and has a completion date of September 5, 2024. This order is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, that runs through December 31, 2025....
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4,568,201,754 units of the drug Keytruda (100 mg/4 ml vial, 4 ml). The contract has a ceiling value of $41,020.75 and a period of performance through May 29, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at $499,999,999 and valid...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB21FQ1A5Delivery Order
This federal contract award is for the delivery of Keytruda 100 mg/4 ml vials to the Defense Logistics Agency (DLA). The $127,339.80 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 31, 2021. The contract has an ultimate completion date of September 22, 2021 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is likely one of many issued under that IDC to ensure the Department of Defense and other federal agencies have access to critical medications like Keytruda.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $127.3k | 8/31/21 |